RIGL

RIGL CapEx to Revenue

0.00%TTM

Retrieved:

RIGL FY CapEx/Revenue%
RIGL FY CapEx/Revenue168.10%-18.01%
1999-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

RIGL capex to revenue history

Capital expenditure as percentage of revenue. The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.

Rigel Pharmaceuticals Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0%
0.2209%
12.8335%
0.3742%
0.4201%
1.1618%
2.4541%
2.4849%
3.6574%
3.9445%
1.8896%
5.0061%
17.0769%
150.0889%
48.4842%
2.848%
18.8%
0%
7.4048%
2.7276%
10.8556%
32.6431%
11.2347%
10.356%
21.1004%
27.3642%
78.8736%

Compare capex to revenue

All RIGL financial metrics · RIGL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.